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Locus coeruleus (LC) provides the sole source of noradrenergic (NA) innervation to hippocampus, and 16 it undergoes significant degeneration early in Alzheimer's disease (AD). Norepinephrine (NE) 17 modulates synaptic transmission and plasticity at hippocampal synapses which likely contributes to 18 hippocampus dependent learning and memory. We previously reported that pharmacological activation 19 of α1 adrenergic receptors (α1ARs) induces long-term depression (LTD) at CA3-CA1 synapses. Here 20
we investigated whether accumulation of endogenous NE via pharmacological blockade of NE 21 transporters (NET) and the NE degradative enzyme, monoamine oxidase (MAO), can induce α1AR 22 LTD, as these inhibitors are used clinically. Further, we sought to determine how degeneration of 23 hippocampal NA innervation, as occurs in AD, impacts α1AR function and α1AR LTD. Bath 24 application of NET and MAO inhibitors in slices from control rats reliably induced α1AR LTD when 25 β adrenergic receptors were inhibited. To induce degeneration of LC-NA innervation, rats were treated 26 with the specific NA neurotoxin DSP-4 and recordings performed 1-3 weeks later when NA axon 27 degeneration had stabilized. Even with 85% loss of hippocampal NA innervation, α1AR LTD was 28 successfully induced using either the α1AR agonist phenylephrine or the combined NET and MAO 29 inhibitors, and importantly, the LTD magnitude was not different from saline-treated control. These 30 data suggest that despite significant decreases in NA input to hippocampus, the mechanisms necessary 31
for the induction of α1AR LTD remain functional. Furthermore, we posit that α1AR activation could 32 be a viable therapeutic target for pharmacological intervention in AD and other diseases involving 33 malfunctions of NA neurotransmission.
Introduction 35
Noradrenergic (NA) input from the locus coeruleus (LC) to hippocampus is critical for hippocampus-36 dependent learning and memory (Gibbs et al., 2010; Harro et al., 1999; Koob et al., 1978; Lemon et 37 al., 2009), and its degeneration in Alzheimer's disease (AD) has been well documented (Forno, 1966; 38 Yamada and Mehraein, 1977; Zarow et al., 2003) . Specifically, loss of LC cell bodies positively 39
correlates with the severity of dementia and duration of the disease in AD patients. In fact, the LC is 40 the first target of pretangle tau pathology, with measurable cell loss occurring in the prodromal phase 41 of AD ( Thomas and Palmiter, 1997a , 1997b , 1997c . Accordingly, 56
blockade of β adrenergic receptors (ARs) reduces NMDAR-dependent LTP in hippocampal slices 57 (Harley, 1991) , while NE application facilitates the induction of LTP in dentate and spatial memory 58 formation through activation of β-ARs ( Grzanna, 1992). Rats were lightly anesthetized with isofluorane and injected IP with DSP-4 (50mg/kg) 99
in saline or saline alone at 48-hour intervals for a total of 3 injections. 100
Drugs and solutions 101
All drugs (Sigma, St. Louis, MO) were prepared as stock solutions and diluted to the appropriate 102 working concentration at the time of electrophysiology. Phenylephrine (Phe, α1AR agonist; in 103 deionized water), propranolol (β-AR antagonist; in DMSO) and prazosin (α1AR antagonist; in DMSO) 104
were prepared fresh daily and atomoxetine (Atmx, NET inhibitor; in deionized water) and clorgiline 105 (Clor, MAO inhibitor; in deionized water) were frozen in 300μL aliquots until used for recordings. 106
Slice preparation and electrophysiological recordings 107
α1AR LTD was induced using the α1AR agonist phenylephrine (Phe,100μM) that was bath applied 108 for 10 or 15 min following a 20 min stable baseline of recorded fEPSPs as done previously (Scheiderer 109 et al., 2004 (Scheiderer 109 et al., , 2008 . Experiments to test whether extracellular accumulation of endogenous NE could 110
induce LTD, as well as to test the functionality of the NA fibers remaining following DSP-4-mediated 111 lesion, slices were exposed to bath application of the NET inhibitor Atmx (500nM) plus the MAO 112
inhibitor Clor (10μM) for 10 or 20 min following stable baseline transmission. Previous reports have 113
documented the ability of NET inhibition to block reuptake of NE and induce increases in extracellular 114 NE (Youdim and Riederer, 1993) . Additionally, selective inhibition of MAO, the enzyme responsible 115
for NE degradation, has also been shown to cause accumulation of NE extrasynaptically (Youdim and  116 Riederer, 1993). Because NE has similar affinity for α-and β-ARs, it was necessary to pharmacology 117 inhibit β-AR activation with propranolol (10µm) to reveal LTD following accumulation of 118 extracellular NE. To ensure the α1AR specificity of the LTD induced by endogenous NE in these 119 recordings, interleaved experiments were conducted in the presence of 10μM prazosin (in addition to 120 the cocktail of Clor, Atmx and propranolol, which is referred to as CAP). 121
Immunohistochemistry 122
Following electrophysiological recordings, 400μm-thick hippocampal slices were stored in 4% 123 paraformaldehyde at 4°C until the time of staining. Twenty-four hours prior to staining, slices were 124 rinsed in phosphate buffered saline (PBS) and then transferred to a 30% sucrose/PBS solution. Tissue 125 was resectioned to 50μm using a freezing microtome. Sections were washed 3 x 10 min in PBS at room 126 temperature and incubated in blocking buffer (10% normal donkey serum (NDS) in 0.3% PBS 127
Triton/PBS) for 90 minutes. Primary antibodies [rabbit anti-tyrosine hydroxylase (TH, 1:200) and 128 mouse anti-dopamine β-hydroxylase (DβH, 1:300); Chemicon, Temecula, CA] were diluted in 129 blocking buffer, and applied to free-floating sections and incubated overnight at 4°C. Slices were 130
washed 3 x 10 min with PBS and were labeled with fluorescence-activated secondary antibodies 131
[donkey anti-rabbit the field of view from one slice per animal was analyzed using ImageJ software. Sequential scans of 137 blue, green, and red channels were obtained and ~20μm stacks of images were collected in a z-axis of 138
1.0-1.5μm step size, averaging 2 scans per image. Maximum projections were generated and used for 139 NE fiber quantification. DβH-positive fibers were measured and counted, following the criterion that 140 only fibers with 4 or more consecutive boutons be considered as a fragment of axon. 141
Data analysis 142
Electrophysiology data were analyzed using custom-written Labview data acquisition and analysis 143 software (Scheiderer et al., 2004 (Scheiderer et al., , 2008 after being filtered at 3 kHz and digitized at 10 kHz. The fEPSP 144 slope was measured and evaluated as a series of 5 averaged raw data points plotted versus time. The 145 LTD magnitude was calculated by comparing the average fEPSP slope recorded during the last 10 min 146 of baseline transmission to the slope at 20 min post drug washout. When more than one slice was 147 recorded per animal for a given experiment (e.g. Phe or Amtx+Clor), the data were averaged together 148
to represent the finding for that animal. Therefore, the reported n refers to animal number. Paired 149 student's t-tests were used for statistical analysis within groups. Unpaired student's t-tests or one-way 150
ANOVAs were used to evaluate statistical significance between groups. The significance level was set 151 at p<0.05 and the data are presented as the mean ± s.e.m. 152
Results 153 α1AR activation induces LTD at CA3-CA1 synapses in rat hippocampus 154
Our laboratory previously reported that bath application of NE or the selective α1AR agonist 155 methoxamine is sufficient to induce a NMDAR-dependent LTD of extracellular fEPSPs at CA3-CA1 156 glutamatergic synapses in hippocampal slices (Scheiderer et al., 2004 (Scheiderer et al., , 2008 . Here, we show that 157 application of another α1AR agonist, Phe (100μM; phenylephrine) also reliably induces α1AR LTD 158 ( Fig. 1A , 84 ± 4% of baseline fEPSP slope (n=6); p<0.01) similar to our previous report (Scheiderer et 159 al., 2004 (Scheiderer et 159 al., , 2008 . To test whether α1AR LTD can also be induced via extracellular accumulation of 160 endogenous NE in hippocampus, the selective NET inhibitor Atmx (500nM) was applied together with 161 an inhibitor of NE degradative enzyme MAO, Clor (10μM). Bath application of to Atmx and Clor did 162 not elicit a significant change in synaptic strength compared to baseline (Fig. 1B1 , 94 ± 5% of baselined 163 fEPSP slope, n=6, p=0.14). However, when we evaluated individual experiments there were clear 164 cases of Atmx and Clor induced depression ( Fig. 1B2 ) and potentiation (Fig. 1B3 ) of the extracellular 165 fEPSP that were masked when all of the experiments were averaged. This variable response can be 166 attributed to coincident global activation of α1, α2, and β-ARs, as all of these receptors are located at 167 pre-or post-synaptic locations at CA3-CA1 synapses. 168
Because activation of β-ARs causes potentiation at CA3-CA1 synapses (Bröcher et al., 1992 (collectively named CAP), and this resulted in reliable, and significant LTD expression ( Fig. 2A , 83 ± 174 6% of baseline fEPSP slope, n=4, p=0.02). The LTD magnitude induced by the selective α1AR agonist 175 Phe (Fig. 1A) is not significantly different from that induced by the combination of NET, MAO, and 176 β-AR inhibition ( Fig. 2A) (p=0.8) . To confirm that the LTD following accumulation of endogenous 177 NE is also mediated by α1AR activation, interleaved experiments were performed with the α1AR 178 antagonist prazosin (10μM) resulting in a complete block of LTD ( Fig. 2B , CAP plus prazosin, 96.5 ± 179 4% of baseline fEPSP slope, n=3 p=0.4). 180
DSP-4 causes a significant decrease in NA innervation in CA1 of hippocampus 181
To determine whether loss of NA input to hippocampus is sufficient to cause deficits in α1AR LTD, 182
the NE specific neurotoxin DSP-4 (50mg/kg, in saline), was administered intraperitoneally at 48-hour 183
intervals for a total of 3 injections (control animals received injections of saline only). DSP-4 targets 184 the NE uptake system and induces alkylation of vital neuronal structures (Ross, 1976) knobby appearance compared to the thin, more delicate fibers found in the control group (Fig. 3A  196 arrows). 197
α1AR LTD remains intact following NA-fiber degeneration 198
We next tested whether systemic treatment with DSP-4 and subsequent ~85% reduction of NA 199 innervation would negatively impact the ability of direct activation of α1ARs by the selective α1AR 200
agonist Phe to induce LTD. Surprisingly, we found that the magnitude of α1AR LTD was not 201 significantly different between saline-treated and DSP-4 treated animals. (Fig. 4A To determine whether the NA fibers surviving neurotoxic damage are able to functionally release NE 208 and activate α1ARs effectively to induce LTD, NET, MAO, and β-ARs antagonists were bath applied. 209
Again surprisingly, α1AR LTD was observed (Fig. 4B , DSP-4: 83 ± 3%, n=11, p<0.001) and the 210 magnitude was not different from saline-treated animals; (Fig. 4B, saline To determine if α1AR LTD induced by endogenous NE release elicits maximal depression and occludes 215 further depression induced by subsequent application of Phe, the drug mixture CAP was bath applied 216
for 10 minutes to induce LTD. In interleaved slices, Phe (100µM) was coapplied with CAP for 15 217 minutes beginning 20 minutes after CAP application to determine if additional LTD could be elicited 218 (Fig. 5 ). We found that no additional LTD could be induced by Phe in the presence of CAP, such that 219 α1AR LTD induced by CAP that was not significantly different when Phe was added to the CAP 220 mixture (denoted CAPP) ( Fig. 5 , CAP: n=6; CAPP: n=10, t(6)=2.08 p=0.0827). 221
Discussion 222
α1AR LTD 223
Here we have established that increasing extracellular accumulation of endogenously released NE can 224 activate α1ARs and induce α1AR LTD at CA3-CA1 synapses in hippocampus. Furthermore, lesion of 225 NA input to hippocampus from the LC did not prevent induction or expression of α1AR LTD, despite 226 the loss of ~85% of hippocampal NA innervation. Surprisingly, the NA fibers that remained following 227 DSP-4 induced lesion release enough NE that can accumulate following NET and MAO inhibition to 228 activate postsynaptic α1ARs at CA3-CA1 synapses to induce LTD. Therefore, these data suggest that 229 in light of severe NE degeneration, α1 ARs remain coupled to their signaling cascade and are able to 230 be activated by specific α1AR agonists or via endogenously released NE from surviving NA fibers to 231 induce LTD. 232 Previously, our lab has shown that M1-acetylcholine receptor (AChR) LTD (mLTD) is lost following 233 degeneration of hippocampal cholinergic innervation from the medial septum, but is rescued when 234 hippocampal NA sympathetic sprouting occurs with an accompanying cholinergic reinnervation of 235 hippocampus at 15% of control levels (Scheiderer et al., 2006) . Because M1 mAChRs and 1ARs 236 couple to the same G protein signaling pathway (Porter et al., 2002) , and we have shown that their 237 simultaneous weak pharmacological activation induces LTD (Scheiderer et al., 2008) , we expected that 238 loss of NA innervation to hippocampus would cause the same deficit in 1AR LTD as we have 239 observed for M1 mAChR LTD following cholinergic degeneration in the absence of sprouting 240 (Scheiderer et al., 2006) . However, the successful expression of α1 AR LTD at synapses in slices with 241 15% NA fibers remaining is consistent with the 'rescued' mLTD by the approximate 15% cholinergic 242 reinnervation stimulated by NA sympathetic sprouting after medial septal lesion. Thus 15% of control 243 cholinergic or NA innervation in hippocampus is enough to maintain function of M1 mAChRs or 1 244
ARs, respectively. Based on these findings, we speculate that α1ARs remain functional in AD and PD 245 patients even with 67.9% and 83.2% cell loss (Marien et al., 2004) . In fact, α1ARs expression is 246 increased in AD patients, but unfortunately, this has been associated with increased aggression in these 247 patients (Sharp et al., 2007; Szot et al., 2006) . Due to this, prazosin, an α1AR antagonist, is being used 248 in AD clinical trials and has been shown to improve aggravation and aggression symptoms (Wang et  249 al., 2010). It is interesting to note that uncoupling of α1AR function and loss of α1AR LTD occurs at 250 glutamatergic synapses in mPFC in adult rats as a consequence of neonatal lesion of the ventral 251 hippocampus (Bhardwaj et al., 2014) . 252
DSP-4 induced lesion of hippocampal NA innervation 253
In humans, the severity of LC degeneration is positively correlated with intensity of AD symptoms and 254 is detectable in the prodromal phase, prior to the onset of cognitive deficits ( we were able to recapitulate the effects of AD-driven LC degeneration with the neurotoxin, DSP-4 in 258 healthy rats. 259
The DSP-4 treatment protocol employed reduced NA innervation by ~85%; additional injections or 260 increases in DSP-4 concentration were not used due to observed increases in animal mortality 261 (unpublished observations). It is important to note that the DSP-4 induced NA lesion is a variable 262 model, as DSP-4 only provides a temporary decrease in NA innervation, whereas neurodegeneration 263 is permanent. In fact, several studies have shown that DSP-4 induced NA degeneration is reversed 264 several months following treatment (Fritschy et al., 1990; Grzanna, 1989, 1992) . The LC-265
NA system is known to be capable of initiating these compensatory mechanisms in response to damage, 266
which includes an increase in NE turnover (Jonsson et al., 1981) and release (Abercrombie and 267
Zigmond, 1989) in surviving cell axons, as well as inducing α and β receptor supersensitivity (Berridge 268 and Dunn, 1990; Dooley et al., 1983; Starke, 2001) . Interestingly, AD patients have elevated NE levels 269 even though there is LC cell loss (Szot et al., 2006) , and α2-AR positive axonal sprouting has been 270 identified in AD post-mortem human hippocampus (Szot et al., 2006) . Thus, it can be postulated that 271 excessive release, in addition to depletion, of NE could also lead to deficits in hippocampal dependent 272 learning and memory, and therefore, synaptic plasticity. Furthermore, the lesion protocol used here 273 may cause increased activation of the NA compensatory mechanisms thought to be responsible for 274 lesion reversal (Fritschy and Grzanna, 1992) . In support of this idea, the DβH positive fiber 275 morphology appears thicker and has a knobby appearance in the DSP-4 treated group compared to 276 saline-treated control (Fig. 3A arrows) . This morphology change could be an early indication of 277 compensatory LC sprouting because as mentioned above, it has been shown DSP-4 induced lesions are 278 not permanent, and after a variable period of time hyperinnervation of NA fibers can occur (Booze et 279 al., 1988; Fritschy and Grzanna, 1992; Kalinin et al., 2006) . Altogether, we were unable to induce a 280 complete loss of all NA hippocampal innervation using DSP-4 and were therefore unable to observe 281 α1AR uncoupling and α1AR LTD loss that we predict would happen in the complete absence of 282 endogenous NE, similar to our previous studies of M1mAChR LTD following complete medial septal 283 lesion (Scheiderer et al., 2006) . 284
The maintenance of α1AR function we observe following DSP-4 induce lesion could explain the 285 inconsistent findings in learning and memory assays following DSP-4 treatment, with some studies 286 reporting minimal effects (Decker and McGaugh, 1991; Ohno et al., 1993 Ohno et al., , 1997 
Conclusions 291
Here we show that pharmacological inhibition of NET and MAO leads to extracellular accumulation 292 of NE which is capable of activating ARs that modulate synaptic efficacy at CA3-CA1 synapses. This finding is important, as NET and MAO inhibitors are used clinically in the treatment of several 294 neurological and neuropsychiatric illness (Castellanos et al., 1996; Zametkin and Rapoport, 1987) . 295
Furthermore, the DSP-4-driven loss of 85% of NA fibers in hippocampus recapitulates the loss 296 cortical projecting LC-cells in human AD (Arendt et al., 2015; Braak et al., 2011; German et al., 1992 ; 297 Grudzien et al., 2007) . The present findings suggest that α1ARs are preserved in CA3-CA1 298 glutamatergic synapses following extensive NA fiber denervation. This preservation of α1AR function 299 may be an effect of compensatory NE levels released from remaining fibers or may be resilient to 300 change in chronically low stimulation settings. These results indicate that NA drugs may provide an 301 avenue for viable therapeutics in AD to treat changes in local NE levels in regions critical for learning 302 and memory. 303
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Figure Legends

